The Pharmaceutical Journal
Vol 272 No 7304 p759
19 June 2004

This article
Reprint   Photocopy

  Acrobat Reader

News summary

GI bleeding and COX-2 inhibitors

Recent increases in the use of selective cyclo-oxygenase-2 inhibitors appear to have been accompanied by an increase in hospital admissions for gastrointestinal bleeds. The events may be directly linked, say researchers (BMJ 2004;328:1415).